Dr. Jamal Misleh, MD
Claim this profileMedical Oncology Hematology Consultants, PA
Expert in Breast Cancer
Studies Cancer
28 reported clinical trials
48 drugs studied
About Jamal Misleh, MD
Education:
- Obtained MD from the University of Miami School of Medicine in 2003.
Experience:
- Completed an Internal Medicine Internship (2003-2004) and Residency (2004-2006) at the Hospital of the University of Pennsylvania.
- Undertook a Fellowship in Hematology/Medical Oncology at the University of Maryland Medical Center (2006-2009).
- Board Certified in Hematology and Medical Oncology by the American Board of Internal Medicine since 2009.
- Affiliated with Medical Oncology Hematology Consultants, PA, and serves as the Director of US Oncology Network Clinical Trials.
Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2
2Cancer
Stage IV
Stage III
NRG1 positive
Affiliated Hospitals
Clinical Trials Jamal Misleh, MD is currently running
ARX788
for HER2-Positive Breast Cancer
This trial tests ARX788, a new IV medicine, for patients with HER2-positive metastatic breast cancer who did not respond well to T-DXd. The medicine targets a specific protein on cancer cells to help stop their growth.
Recruiting1 award Phase 28 criteria
Radium-223 + Docetaxel
for Prostate Cancer
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.
Recruiting2 awards Phase 323 criteria
More about Jamal Misleh, MD
Clinical Trial Related2 years of experience running clinical trials · Led 28 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Jamal Misleh, MD has experience with
- Pembrolizumab
- Abemaciclib
- Placebo
- LOXO-305
- Rituximab
- Botensilimab
Breakdown of trials Jamal Misleh, MD has run
Breast Cancer
Cancer
Lymphoma
Colorectal Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Jamal Misleh, MD specialize in?
Is Jamal Misleh, MD currently recruiting for clinical trials?
Are there any treatments that Jamal Misleh, MD has studied deeply?
What is the best way to schedule an appointment with Jamal Misleh, MD?
What is the office address of Jamal Misleh, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.